Ligand Pharmaceuticals Inc (LGND)
72.52
-6.35
(-8.05%)
USD |
NASDAQ |
Apr 18, 16:00
72.61
+0.09
(+0.12%)
After-Hours: 20:00
Ligand Pharmaceuticals Profit Margin (Quarterly): 64.72% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.72% |
| September 30, 2023 | -31.26% |
| June 30, 2023 | 8.69% |
| March 31, 2023 | 95.38% |
| December 31, 2022 | -34.70% |
| September 30, 2022 | 0.68% |
| June 30, 2022 | -1.79% |
| March 31, 2022 | -42.13% |
| December 31, 2021 | -14.68% |
| September 30, 2021 | 21.17% |
| June 30, 2021 | 36.29% |
| March 31, 2021 | 32.83% |
| December 31, 2020 | 12.22% |
| September 30, 2020 | -16.01% |
| June 30, 2020 | 53.32% |
| March 31, 2020 | -72.77% |
| December 31, 2019 | -27.27% |
| September 30, 2019 | -61.48% |
| June 30, 2019 | -57.71% |
| March 31, 2019 | |
| December 31, 2018 | -71.29% |
| September 30, 2018 | |
| June 30, 2018 | 81.25% |
| March 31, 2018 | 80.63% |
| December 31, 2017 | -13.89% |
| Date | Value |
|---|---|
| September 30, 2017 | 25.25% |
| June 30, 2017 | 21.64% |
| March 31, 2017 | 17.35% |
| December 31, 2016 | -8.19% |
| September 30, 2016 | 4.86% |
| June 30, 2016 | -31.61% |
| March 31, 2016 | 22.29% |
| December 31, 2015 | 29.92% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 5.16% |
| December 31, 2014 | 30.68% |
| September 30, 2014 | 8.55% |
| June 30, 2014 | 15.01% |
| March 31, 2014 | 13.14% |
| December 31, 2013 | 12.68% |
| September 30, 2013 | 15.11% |
| June 30, 2013 | 63.58% |
| March 31, 2013 | 12.83% |
| December 31, 2012 | 7.80% |
| September 30, 2012 | -3.04% |
| June 30, 2012 | -44.04% |
| March 31, 2012 | 20.10% |
| December 31, 2011 | 36.22% |
| September 30, 2011 | -72.77% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-72.77%
Minimum
Mar 2020
95.38%
Maximum
Mar 2023
-1.82%
Average
-1.79%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 0.88% |
| ADMA Biologics Inc | -23.88% |
| Viking Therapeutics Inc | -- |
| Corcept Therapeutics Inc | 23.16% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.96% |
| Return on Assets | 6.71% |
| Return on Invested Capital | 7.60% |
| Gross Profit Margin (Quarterly) | 94.16% |
| Operating Margin (Quarterly) | -11.95% |
| Return on Net Operating Assets | 9.83% |